Research Article
The Role of EUS-BD in the Management of Malignant Biliary Obstruction: The Indonesian Perspective
Table 5
Factors related to the clinical success rate of EUS-BD.
| Variables | Clinical success rate | | % | RR | 95% CI | value |
| Primary disease | | | | | | Tumor of the head of pancreas | 13 | 54.2 | 2.375 | 1.402–4.025 | 0.030 | Periampullary tumor | 10 | 41.6 | 2.111 | 1.314–3.391 | 0.047 | Cholangiocarcinoma | 1 | 4.2 | 1.056 | 0.949–1.174 | 0.792 | Technique | | | | | | Choledochoduodenostomy | 23 | 95.8 | 0.739 | 0.580–0.942 | 0.750 | Hepaticogastrostomy | 1 | 4.2 | 1.353 | 1.061–1.725 | 1.0 | EUS-BD indication | | | | | | Difficult cannulation | 16 | 66.7 | 1.0 | 0.613–1.632 | 0.698 | Unidentifiable ampulla | 8 | 33.3 | 1.0 | 0.230–4.349 | 1.0 |
|
|